Obesity-drug maker Metsera posts largest gain as IPOs defy market swoon
Oil company Natural Resources and medical-device maker Beta Bionics shrug off a down market to gain in their trading debuts.
Metsera hits $2.7 bln valuation as shares surge 42% in Nasdaq debut
Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...
Metsera IPO opens 42% higher
Metsera, a clinical-stage biotechnology firm, debuted on the Nasdaq Global Select Market today. After initially offering its ...
Metsera sees stock rally 54% following $275M IPO
Shares of newly public Metsera (NASDAQ:MTSR), which is developing ultra-long-acting obesity drugs, rallied 54% following a ...
devdiscourse20h
Health Sector Headlines: High-Stakes Decisions and Market Moves
Recent health news highlights include a review of the safety of Alzheimer's drug Leqembi, legal charges against a New York ...
Opening Day: Infinity Natural Resources valued at $1.3B in market debut
Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...
Indiatimes22h
IPO News
Malpani Pipes IPO: Ahead of listing, Malpani Pipes And Fittings' shares traded at a Rs 10-11 GMP on Friday, an 11% premium over the Rs 90 IPO price band. Net IPO proceeds will fund capital expenditure ...